You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 119 No. 8, August 2001 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinical Sciences
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (40)
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Pediatric Ophthalmology
 •Retinal/ Chorioretinal Disorders
 •Evidence-Based Medicine
 •Randomized Controlled Trial
 •Articles for Residents
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Multicenter Trial of Cryotherapy for Retinopathy of Prematurity

Ophthalmological Outcomes at 10 Years

Cryotherapy for Retinopathy of Prematurity Cooperative Group

Arch Ophthalmol. 2001;119:1110-1118.

Objective  To evaluate outcomes at 10 years after randomization for eyes undergoing cryotherapy vs eyes serving as controls, for patients enrolled in the Multicenter Trial of Cryotherapy for Retinopathy of Prematurity (CRYO-ROP).

Methods  The randomized cohort originally consisted of 291 preterm children with birth weights less than 1251 g who developed a defined threshold of ROP severity in one or both eyes. Patients with bilateral threshold ROP (n = 240) were randomly assigned to receive cryotherapy to one eye and no cryotherapy to the other eye. Those with ROP of less severity than threshold in the fellow eye ("asymmetric"; n = 51) were randomly assigned to cryotherapy or no cryotherapy in the eye with threshold ROP. Ten years later, a tester who was masked to treatment status of each eye measured distance and near visual acuity, with "unfavorable" outcome being 20/200 or worse. Patients also were evaluated by study-certified ophthalmologists who assessed ROP residua primarily in the posterior pole of the fundus, with unfavorable outcome being a posterior retinal fold or worse.

Results  For the 247 children examined, both functional and structural primary outcomes showed fewer unfavorable outcomes in treated vs control eyes: 44.4% vs 62.1% (P<.001) for distance visual acuity and 27.2% vs 47.9% (P<.001) for fundus status. Near acuity results were similar to those for distance (42.5% vs 61.6%; P<.001). Total retinal detachments had continued to occur in control eyes, increasing from 38.6% at 51/2 years to 41.4% at 10 years, while treated eyes remained stable (at 22.0%). A previously disturbing subgroup trend that more control eyes than treated eyes had visual acuity of 20/40 or better (in the 51/2-year report) was no longer present at 10 years; eyes that received cryotherapy were found at least as likely as control eyes to have 20/40 or better visual acuity.

Conclusions  At 10 years, eyes that had received cryotherapy were much less likely than control eyes to be blind. A previous trend for a higher proportion of sighted control eyes than sighted treated eyes to show acuity in the normal range was not confirmed. The results show long-term value from cryotherapy in preserving visual acuity in eyes with threshold ROP.


From the Casey Eye Institute, Oregon Health Sciences University, Portland. The authors have no affiliation with or financial interest in the subject matter or materials discussed in the article (eg, employment, consultancies, stock ownership, honoraria), with the exception of Velma Dobson, PhD, who receives a small royalty from the sale of Teller acuity cards.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTERS

We Can Aim at Better Results in Coming Years
Subhadra Jalali and Anjli Hussain
Arch Ophthalmol. 2006;124(4):604-605.
EXTRACT | FULL TEXT  

We Can Aim at Better Results in Coming Years—Reply
Earl A. Palmer
Arch Ophthalmol. 2006;124(4):605-606.
EXTRACT | FULL TEXT  

RELATED ARTICLES

Effect of Retinal Ablative Therapy for Threshold Retinopathy of Prematurity: Results of Goldmann Perimetry at the Age of 10 Years
Cryotherapy for Retinopathy of Prematurity Cooperative Group
Arch Ophthalmol. 2001;119(8):1120-1125.
ABSTRACT | FULL TEXT  

Contrast Sensitivity at Age 10 Years in Children Who Had Threshold Retinopathy of Prematurity
Cryotherapy for Retinopathy of Prematurity Cooperative Group
Arch Ophthalmol. 2001;119(8):1129-1133.
ABSTRACT | FULL TEXT  

Ten-Year Follow-up From the CRYO-ROP Study
William Tasman
Arch Ophthalmol. 2001;119(8):1200-1201.
EXTRACT | FULL TEXT  

Archives of Ophthalmology Reader's Choice: Continuing Medical Education
Arch Ophthalmol. 2001;119(8):1234-1235.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Recognition Acuity, Grating Acuity, Contrast Sensitivity, and Visual Fields in 6-Year-Old Children
Hargadon et al.
Arch Ophthalmol 2010;128:70-74.
ABSTRACT | FULL TEXT  

Retinopathy of prematurity
Wilson and Fielder
BMJ 2008;337:a2648-a2648.
FULL TEXT  

Evaluating the Cryotherapy for Retinopathy of Prematurity Study (CRYO-ROP)
Mills
Arch Ophthalmol 2007;125:1276-1281.
FULL TEXT  

The Early Treatment for Retinopathy Of Prematurity Study: structural findings at age 2 years
The Early Treatment for Retinopathy of Prematurity
Br J Ophthalmol 2006;90:1378-1382.
ABSTRACT | FULL TEXT  

Long term functional and structural outcomes of laser therapy for retinopathy of prematurity
McLoone et al.
Br J Ophthalmol 2006;90:754-759.
ABSTRACT | FULL TEXT  

The temporal retinal vessel angle and infants born preterm
Wilson et al.
Br J Ophthalmol 2006;90:702-704.
ABSTRACT | FULL TEXT  

Visual outcomes after 3-port lens-sparing vitrectomy in stage 4 retinopathy of prematurity.
Lakhanpal et al.
Arch Ophthalmol 2006;124:675-679.
ABSTRACT | FULL TEXT  

We can aim at better results in coming years.
Jalali and Hussain
Arch Ophthalmol 2006;124:604-605.
FULL TEXT  

Diode laser versus cryotherapy in treatment of ROP.
O'Keefe and Kirwan
Br J Ophthalmol 2006;90:402-403.
FULL TEXT  

Accuracy and reliability of remote retinopathy of prematurity diagnosis.
Chiang et al.
Arch Ophthalmol 2006;124:322-327.
ABSTRACT | FULL TEXT  

Visual Acuity at 10 Years in Cryotherapy for Retinopathy of Prematurity (CRYO-ROP) Study Eyes: Effect of Retinal Residua of Retinopathy of Prematurity.
Cryotherapy for Retinopathy of Prematurity Coopera
Arch Ophthalmol 2006;124:199-202.
ABSTRACT | FULL TEXT  

Screening Examination of Premature Infants for Retinopathy of Prematurity
Section on Ophthalmology et al.
Pediatrics 2006;117:572-576.
ABSTRACT | FULL TEXT  

Outcome of Eyes Developing Retinal Detachment During the Early Treatment for Retinopathy of Prematurity Study (ETROP)
Repka et al.
Arch Ophthalmol 2006;124:24-30.
ABSTRACT | FULL TEXT  

Contrast sensitivity in 10 year old preterm and full term children: a population based study
Larsson et al.
Br J Ophthalmol 2006;90:87-90.
ABSTRACT | FULL TEXT  

A Population-Based Study on the Visual Outcome in 10-Year-Old Preterm and Full-Term Children
Larsson et al.
Arch Ophthalmol 2005;123:825-832.
ABSTRACT | FULL TEXT  

15-Year Outcomes Following Threshold Retinopathy of Prematurity: Final Results From the Multicenter Trial of Cryotherapy for Retinopathy of Prematurity
Cryotherapy for Retinopathy of Prematurity Coopera
Arch Ophthalmol 2005;123:311-318.
ABSTRACT | FULL TEXT  

Premature for Life
Fielder
Arch Ophthalmol 2005;123:392-394.
FULL TEXT  

Threshold ROP
Clark
Br J Ophthalmol 2004;88:1484-1484.
FULL TEXT  

Variations in the morphology of retinopathy of prematurity in extremely low birthweight infants
Schulenburg and Tsanaktsidis
Br J Ophthalmol 2004;88:1500-1503.
ABSTRACT | FULL TEXT  

Health-Related Quality of Life at Age 10 Years in Very Low-Birth-Weight Children With and Without Threshold Retinopathy of Prematurity
CRYO-ROP Cooperative Group
Arch Ophthalmol 2004;122:1659-1666.
ABSTRACT | FULL TEXT  

Conditional Knockdown of Tubedown-1 in Endothelial Cells Leads to Neovascular Retinopathy
Wall et al.
IOVS 2004;45:3704-3712.
ABSTRACT | FULL TEXT  

Educational and Social Competencies at 8 Years in Children With Threshold Retinopathy of Prematurity in the CRYO-ROP Multicenter Study
Msall et al.
Pediatrics 2004;113:790-799.
ABSTRACT | FULL TEXT  

The nine lives of retinopathy of prematurity
Good
Br J Ophthalmol 2004;88:160-161.
FULL TEXT  

Revised Indications for the Treatment of Retinopathy of Prematurity: Results of the Early Treatment for Retinopathy of Prematurity Randomized Trial
Early Treatment for Retinopathy of Prematurity Coo
Arch Ophthalmol 2003;121:1684-1694.
ABSTRACT | FULL TEXT  

Preliminary Results of Treatment of Eyes With High-Risk Prethreshold Retinopathy of Prematurity in the Early Treatment for Retinopathy of Prematurity Randomized Trial
Fielder
Arch Ophthalmol 2003;121:1769-1771.
FULL TEXT  

The Use of Oxygen in Neonatal Medicine: Half a Century of Uncertainty
Askie and Tin
NeoReviews 2003;4:e340-348.
FULL TEXT  

Specificity of Subnormal {Delta}PO2 for Retinal Neovascularization in Experimental Retinopathy of Prematurity
Zhang et al.
IOVS 2003;44:3551-3555.
ABSTRACT | FULL TEXT  

Can Changes in Clinical Practice Decrease the Incidence of Severe Retinopathy of Prematurity in Very Low Birth Weight Infants?
Chow et al.
Pediatrics 2003;111:339-345.
ABSTRACT | FULL TEXT  

What do you do about ROP screening in "big" babies?
Quinn
Br J Ophthalmol 2002;86:1072-1073.
FULL TEXT  

Contrast Sensitivity at Age 10 Years in Children Who Had Threshold Retinopathy of Prematurity
Cryotherapy for Retinopathy of Prematurity Coopera
Arch Ophthalmol 2001;119:1129-1133.
ABSTRACT | FULL TEXT  

Ten-Year Follow-up From the CRYO-ROP Study
Tasman
Arch Ophthalmol 2001;119:1200-1201.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.